Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Paul J. Rychwalski, MD, is a full-time staff member with Cleveland Clinic Children’s Hospital Department of Ophthalmology and Cole Eye Institute. He sees patients at Main Campus and at Cole Eye Institute’s Beachwood location. In addition to his clinical appointment, Dr. Rychwalski is also an Associate Professor at Case Western Reserve School of Medicine, Lerner College of Medicine
Dr. Rychwalski is board certified in ophthalmology. He completed his undergraduate degree in biology and chemistry at University of Utah in Salt Lake City, and he earned his medical degree from Medical College of Wisconsin in Milwaukee. His post-graduate training includes an ophthalmology residency at Saint Louis University School of Medicine and Saint Louis University Hospital, as well as a pediatric ophthalmology and adult strabismus Fellowship at University of Kentucky Chandler Medical Center in Lexington.
Dr. Rychwalski is a member of several professional organizations. He is a Fellow of the American Academy of Ophthalmology and the American Academy of Pediatrics. He is also a member of the American Association for Pediatric Ophthalmology and Strabismus and the Association for Research in Vision and Ophthalmology, among others.
Dr. Rychwalski has been recognized as one of America’s Top Ophthalmologists by Consumer’s Research Council of America, and he has been named in “Best Doctors in America” since 2005 by the online resource Best Doctors, Inc. In addition, Dr. Rychwalski has volunteered his time to serve on medical missions to Gansu Providence, China, Columbia, and Romania. He also has served as Medical Advisor for the Cleveland Sight Center and as Medical Advisor to the Board of Directors for the Visually Impaired Pre-school Services, among other outreach activities.
Dr. Rychwalski has published multiple research articles in peer-reviewed journals, as well as having contributed abstracts and presentations at a number of professional association meetings.
His specialty interests include childhood and adult strabismus, pediatric cataract and IOL placement, pediatric glaucoma and retinopathy of prematurity (ROP). He is fluent in English and Spanish.
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland
Clinic's procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. The Cleveland Clinic requires its doctors to approve the public disclosures of their scientific collaborations with industry. As of 8/31/2014 the review process regarding Dr. Rychwalski's disclosure had not been completed. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.